FDA approves Adlyxin to treat type 2 diabetes
Understanding GLP-1 qualification criteria and BMI requirements for GLP-1 therapy can also be relevant if you are considering switching medications or adjusting your treatment plan
My patients brain fog was almost certainly not caused by her statin and neither was her achiness her muscle enzymes were normal
In March 2024, Novo Nordisk A/S stated that ozempic (semaglutide) 1.0 mg shows a 24% lower risk of kidney disease events in type 2 diabetes and chronic kidney disease in the FLOW trial
Most importantly, developing nutrition-embedded standards and guidelines for sustainable eating is expected to give everyone a tastier diet 42
However, the benefits can be significant, including weight loss, improved blood sugar control, lowered blood pressure, and reduced cholesterol levels